2009
DOI: 10.1016/j.ejmech.2009.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of spermine conjugates with acidic retinoids with potent ribonuclease P inhibitory activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
4

Year Published

2013
2013
2020
2020

Publication Types

Select...
2
2
1

Relationship

1
4

Authors

Journals

citations
Cited by 17 publications
(10 citation statements)
references
References 23 publications
(23 reference statements)
0
6
0
4
Order By: Relevance
“…Although no detailed mechanistic studies have been so far carried out, it appears from many existing experimental evidence that RASP shows more potent pharmacological effect to the parent retinoid retinoic acid (atRA) with significantly lower toxic effects. Indeed, in several experiments RASP has shown notably improved activity compared to a simple mixture of free atRA and spermine (SPM) in the ratio 2:1 (Magoulas et al., ). In addition, although the currently used retinoids cause skin inflammation, this compound is expected on the contrary to show an anti‐inflammatory activity (Papaioannou et al., ; Hadjipavlou et al., ).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Although no detailed mechanistic studies have been so far carried out, it appears from many existing experimental evidence that RASP shows more potent pharmacological effect to the parent retinoid retinoic acid (atRA) with significantly lower toxic effects. Indeed, in several experiments RASP has shown notably improved activity compared to a simple mixture of free atRA and spermine (SPM) in the ratio 2:1 (Magoulas et al., ). In addition, although the currently used retinoids cause skin inflammation, this compound is expected on the contrary to show an anti‐inflammatory activity (Papaioannou et al., ; Hadjipavlou et al., ).…”
Section: Discussionmentioning
confidence: 99%
“…It should be noted that the clinical application of retinoids to the management of recalcitrant and incurable in the past neoplastic, immunological, and keratinization disorders has introduced a real revolution in dermatological and other medical fields (Stefanaki et al, 2005;Strauss et al, 2007;Carr et al, 2011;Sanz and Lo-Coco, 2011;Sbidian et al, 2011). Although no detailed mechanistic studies have been so far carried out, it appears from many existing experimental evidence that RASP shows more potent pharmacological effect to the parent retinoid retinoic acid (atRA) with significantly lower toxic effects. Indeed, in several experiments RASP has shown notably improved activity compared to a simple mixture of free atRA and spermine (SPM) in the ratio 2:1 (Magoulas et al, 2009). In addition, although the currently used retinoids cause skin inflammation, this compound is expected on the contrary to show an anti-inflammatory activity Hadjipavlou et al, 2010).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Peptide was synthesized on NovaSyn TGA resin at a 0. vD3-succinic acid-NHS) were synthesized according to literatures. 18,19 The lysine residue-protected peptide (1 mM) and vitamin-NHS (10 mM) were dissolved in dimethylformamide (DMF). N,N-Diisopropylethylamine (10 mM) was added to the solution and reacted at room temperature overnight under nitrogen.…”
Section: Synthesis Of Lysine Residue-protected Peptidementioning
confidence: 99%